Fundraising Fox
Cariad Chester
InvestorManaging Partner at TCG Crossover
Find your path to Cariad
Sign up to see every warm intro you have to Cariad
- Paths you didn't know you had: your email and LinkedIn already hold routes to Cariad. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing Partner who previously was a Managing Director at Aquilo Capital investing in biotech therapeutics, and before that a cancer research scientist at Stanford. Holds a B.A. from Swarthmore College.
Contact· self-published, not guessed
Deals · 1
Ollin Biosciences, Inc.Board seat
via TCG Crossover · filed Jun 2026 · $330M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at TCG Crossover
Frequently asked questions
- Who is Cariad Chester?
- Managing Partner who previously was a Managing Director at Aquilo Capital investing in biotech therapeutics, and before that a cancer research scientist at Stanford. Holds a B.A. from Swarthmore College.
- Where does Cariad Chester work?
- Cariad Chester is Managing Partner at TCG Crossover.
- What boards does Cariad Chester sit on?
- Cariad Chester holds tracked board seats at Ollin Biosciences, Inc., Plexium.
About this profile. Compiled from public sources — TCG Crossover's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights